Astra Zeneca plans to exit manufacturing at Bangalore – Times of India

NEW DELHI: Drug firm AstraZeneca Pharma will exit manufacturing at its only plant based in Bangalore, as part of a “global strategic review’’. The company with revenues of over Rs 1000 crore, feels that it can derive more value for its shareholders by transferring core manufacturing to a contract manufacturer.
As a part of AstraZeneca’s ongoing strategic review of its global manufacturing and supply network, the company intends to exit the manufacturing site in Bangalore, in due course, it said in a stock exchange filing.
The company will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as a contract manufacturing organisation (CMO) for the company’s products currently manufactured or packaged at this site, subject to receipt of necessary statutory approvals, it added.

Source link

We will be happy to hear your thoughts

Leave a reply

Shopping cart